174 related articles for article (PubMed ID: 34338126)
1. COVID-19 vaccines approved in the European Union: current evidence and perspectives.
Bellino S
Expert Rev Vaccines; 2021 Oct; 20(10):1195-1199. PubMed ID: 34338126
[No Abstract] [Full Text] [Related]
2. Messengers of hope.
Nat Biotechnol; 2021 Jan; 39(1):1. PubMed ID: 33376248
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccines: the importance of transparency and fact-based education.
Cohen AF; van Gerven J; Burgos JG; de Boer A; Foucher RAM; Flore H; Teitelbaum Z; van Eden W; Webb A; Cremers S
Br J Clin Pharmacol; 2020 Nov; 86(11):2107-2110. PubMed ID: 33464636
[No Abstract] [Full Text] [Related]
4. In brief: Third dose of mRNA-based COVID-19 vaccines for immunocompromised persons.
Med Lett Drugs Ther; 2021 Sep; 63(1633):145-146. PubMed ID: 34550960
[No Abstract] [Full Text] [Related]
5. In brief: Pfizer/BioNTech COVID-19 vaccine authorized for adolescents 12-15 years old.
Med Lett Drugs Ther; 2021 May; 63(1625):81. PubMed ID: 34101717
[No Abstract] [Full Text] [Related]
6. Mix-and-match COVID vaccines: the case is growing, but questions remain.
Lewis D
Nature; 2021 Jul; 595(7867):344-345. PubMed ID: 34211168
[No Abstract] [Full Text] [Related]
7. COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Scharf RE; Alberio L
Hamostaseologie; 2021 Jun; 41(3):179-182. PubMed ID: 34192777
[No Abstract] [Full Text] [Related]
8. Cash payments in Africa could boost vaccine uptake.
Arezki R
Nature; 2021 Aug; 596(7870):9. PubMed ID: 34345045
[No Abstract] [Full Text] [Related]
9. FDA authorizes Moderna COVID-19 vaccine.
Med Lett Drugs Ther; 2021 Jan; 63(1616):9-10. PubMed ID: 33512345
[No Abstract] [Full Text] [Related]
10. Vaccine safety - is the SARS-CoV-2 vaccine any different?
Tau N; Yahav D; Shepshelovich D
Hum Vaccin Immunother; 2021 May; 17(5):1322-1325. PubMed ID: 33270474
[TBL] [Abstract][Full Text] [Related]
11. Severe mental illness: reassessing COVID-19 vaccine priorities.
Siva N
Lancet; 2021 Feb; 397(10275):657. PubMed ID: 33610199
[No Abstract] [Full Text] [Related]
12. COVID-19 boosters in rich nations will delay vaccines for all.
Chagla Z; Pai M
Nat Med; 2021 Oct; 27(10):1659-1660. PubMed ID: 34465921
[No Abstract] [Full Text] [Related]
13. Maximizing number of doses drawn from multi-dose COVID-19 vaccines by minimizing dead-volume.
Le Daré B; Bacle A; Lhermitte R; Lesourd F; Lurton Y
J Travel Med; 2021 Jun; 28(4):. PubMed ID: 33772277
[No Abstract] [Full Text] [Related]
14. Reporting of AstraZeneca studies may have caused vaccine reservations.
Bignardi G
BMJ; 2021 Apr; 373():n937. PubMed ID: 33846122
[No Abstract] [Full Text] [Related]
15. Equitable global access to coronavirus disease 2019 vaccines.
Schwartz JL
BMJ; 2020 Dec; 371():m4735. PubMed ID: 33323384
[No Abstract] [Full Text] [Related]
16. Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant.
Rubin EJ; Baden LR; Abdool Karim SS; Morrissey S
N Engl J Med; 2021 Jan; 384(2):e14. PubMed ID: 33497556
[No Abstract] [Full Text] [Related]
17. A million-dose success for Nepal: insights from Nepal's national vaccine deployment plan against COVID-19.
Bhattarai S; Dhungana J
J Travel Med; 2021 Jun; 28(4):. PubMed ID: 33668060
[No Abstract] [Full Text] [Related]
18. Reflections on SARS-CoV-2 new strain contagiousness and its prevention with mRNA vaccines.
García-Vigil JL; García-Alvarez JL
Gac Med Mex; 2021; 157(3):318. PubMed ID: 34667321
[No Abstract] [Full Text] [Related]
19. Free licensing of vaccines to end the COVID-19 crisis.
Bozorgmehr K; Jahn R; Stuckler D; McKee M
Lancet; 2021 Apr; 397(10281):1261-1262. PubMed ID: 33743843
[No Abstract] [Full Text] [Related]
20. COVID19 meets the antivaccine movement.
Hotez PJ
Microbes Infect; 2020; 22(4-5):162-164. PubMed ID: 32442682
[No Abstract] [Full Text] [Related]
[Next] [New Search]
